An Open-Label, Rater-Blinded, Flexible-Dose, 8-Week Trial of Escitalopram in Patients With Major Depressive Disorder With Atypical Features

Objectives: Although selective serotonin reuptake inhibitors (SSRIs) have become the standard of care for the treatment of major depressive disorder (MDD), limited data exist to support their use in MDD with atypical features. The current study investigates the efficacy of the SSRI escitalopram in a...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Pae, Chi-Un, Masand, Prakash S., Peindl, Kathleen, Mannelli, Paolo, Han, Changsu, Marks, David M., Patkar, Ashwin A.
Format: Artigo
Langue:Inglês
Publié: Physicians Postgraduate Press, Inc. 2008
Sujets:
Original Articles
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC2446493/
https://ncbi.nlm.nih.gov/pubmed/18615172
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires